Bridgewater Associates’s Exelon EXC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$827K Sell
16,865
-2,886
-15% -$134K ﹤0.01% 819
2025
Q4
$861K Buy
+19,751
New +$901K ﹤0.01% 908
2024
Q3
Sell
-7,154
Closed -$248K 822
2024
Q2
$248K Sell
7,154
-112,867
-94% -$4.17M ﹤0.01% 842
2024
Q1
$4.51M Buy
120,021
+73,170
+156% +$2.61M 0.02% 393
2023
Q4
$1.68M Sell
46,851
-178,004
-79% -$6.86M 0.01% 550
2023
Q3
$8.5M Buy
224,855
+205,976
+1,091% +$8.39M 0.05% 262
2023
Q2
$769K Buy
+18,879
New +$780K ﹤0.01% 610
2023
Q1
Sell
-342,339
Closed -$14.8M 783
2022
Q4
$14.8M Buy
342,339
+185,179
+118% +$7.32M 0.08% 189
2022
Q3
$5.89M Sell
157,160
-265,352
-63% -$11.7M 0.03% 348
2022
Q2
$19.1M Buy
422,512
+159,754
+61% +$7.51M 0.08% 214
2022
Q1
$12.5M Buy
262,758
+205,203
+357% +$8.69M 0.05% 251
2021
Q4
$2.37M Buy
+57,555
New +$2.17M 0.01% 437
2020
Q3
Sell
-10,715
Closed -$277K 468
2020
Q2
$277K Sell
10,715
-12,813
-54% -$340K ﹤0.01% 337
2020
Q1
$618K Buy
+23,528
New +$740K 0.01% 263
2018
Q2
Sell
-30,442
Closed -$847K 485
2018
Q1
$847K Buy
+30,442
New +$822K 0.01% 296
2017
Q2
Sell
-74,438
Closed -$1.91M 361
2017
Q1
$1.91M Sell
74,438
-246,199
-77% -$6.27M 0.02% 153
2016
Q4
$8.12M Buy
320,637
+181,839
+131% +$4.31M 0.08% 94
2016
Q3
$3.3M Buy
+138,798
New +$3.49M 0.03% 162
2016
Q2
Sell
-65,134
Closed -$1.67M 352
2016
Q1
$1.67M Sell
65,134
-1,026,411
-94% -$23M 0.02% 198
2015
Q4
$21.6M Buy
1,091,545
+154,468
+16% +$3.13M 0.28% 16
2015
Q3
$19.9M Buy
937,077
+918,887
+5,052% +$20.7M 0.27% 25
2015
Q2
$408K Buy
+18,190
New +$436K ﹤0.01% 280
2014
Q4
Sell
-15,659
Closed -$381K 368
2014
Q3
$381K Buy
+15,659
New +$367K ﹤0.01% 307
2014
Q1
Sell
-169,458
Closed -$3.31M 361
2013
Q4
$3.31M Buy
+169,458
New +$3.41M 0.03% 145

Other funds holding EXC

Bridgewater Associates's EXC Position: Q1 2026 in Review

Bridgewater Associates reduced its Exelon (EXC) stake by 15% in Q1 2026, selling an estimated $134K and leaving 16,865 shares worth $827K. The position accounts for ﹤0.01% of the portfolio, ranked #819.

Bridgewater Associates first reported a position in EXC in Q4 2013 and has held it in 24 quarters since. The position peaked at $21.6M in Q4 2015. 1,277 funds tracked by Wall St. Rank hold EXC as of Q1 2026.

  • Bridgewater Associates held 16,865 shares of Exelon worth $827K as of Q1 2026.
  • Bridgewater Associates sold 2,886 Exelon shares in Q1 2026, an estimated $134K.
  • Exelon made up ﹤0.01% of Bridgewater Associates's portfolio in Q1 2026, its #819 holding.
  • Bridgewater Associates first reported a position in Exelon in Q4 2013 and has held it in 24 quarters since.
  • Bridgewater Associates's Exelon position peaked at $21.6M in Q4 2015.
  • 1,277 funds tracked by Wall St. Rank held Exelon as of Q1 2026.

Based on Bridgewater Associates's 13F filing for Q1 2026, filed 15 May 2026.